Biosimilars USA 2018

  • 14-15 Nov 2018
  • Renaissance Woodbridge Hotel, Iselin, NJ, United States

Description

Biosimilars USA 2018 is a conference dedicated to biosimilar manufacturing and commercialization considerations specific to the United States.

Biosimilars USA 2018 covers topics such as:

  • Different device design options
  • Challenges to gaining the FDAs Interchangeability status
  • The FDAs CMC finger print comparability that requires a minimum of 10 batches for statistical considerations
  • Routes to take if your biosimilar has a better formulation and/or administration than the originator
  • How to meet high GMP compliance when manufacturing outside of the US
  • Whether more batches lead to better clinical trial outcomes
  • How to get onto patient formularies, and the important role pharmacy benefit manages have in achieving this
  • Whether the biosimilar industry can provide co-payments and other healthcare benefits to patients to successfully complete with originators

Biosimilars USA 2018 brings together biosimilar experts and industry including:

  • Scientific Directors
  • Medical Directors
  • Directors
  • VP’s
  • Team Leaders
  • Managers
  • Consultants
  • Partners
  • Attorneys

Past Events

Important

Please, check "Biosimilars USA" official website for possible changes, before making any traveling arrangements

Event Categories

Health & Medicine: Pharma
Science: Biochemistry, Life Sciences & Biology

Other Events with Similar Categories

Other Events with Similar Location or Organizer

Featured Conferences & Exhibitions